MedTrace Logo

Absorbable Interface Screw Clinical Trial

NCT05431790 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2022-06-24

No results posted yet for this study

Summary

Validation of the safety and efficacy of absorbable interface screws for clinical use

Conditions

  • Anterior Cruciate Ligament Rupture

Interventions

DEVICE

Absorbable interface screws manufactured by Natong Biotechnology

Anterior cruciate ligament reconstruction uses absorbable interface screws manufactured by Natong Biotechnology.

DEVICE

Absorbable interface screws manufactured by INION.

Reconstruction of anterior cruciate ligament using Inion Oy absorbable interface scews from INION, Finland

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-30
Primary Completion
2023-05-30
Completion
2023-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05431790 on ClinicalTrials.gov